Clinical Trial Update: A Longitudinal Study of Amyotrophic Lateral Sclerosis (ALS) Biomarkers

View source ↗

Summary

Massachusetts General Hospital completed a longitudinal study investigating biomarkers in amyotrophic lateral sclerosis, contributing data on ALS biomarkers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Amyotrophic Lateral Sclerosis, Nervous System Diseases | Status: COMPLETED